Financial
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
HQ Nigeria · Middle East & Africa
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
Products not yet catalogued.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Aug 2026: co-founder Adegoke Olubusi stepped down as CEO after nearly a decade; no reason was given and the company had not commented at the time. Co-founder Dimeji Sofowora is now reported as CEO.
No data breaches, cyber incidents or regulator action involving Helium Health found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
EHR and health software supplier; no regulatory or clinical safety actions involving Helium Health found in HSH's search of the last 24 months.
Nov 2026: Helium Health received a $2.5m Google.org grant to deploy clinical AI for maternal care via its HeliumMum programme, launching with Lagos State and extending to Delta, Kano and Oyo States.
No competitors linked yet.